Marex Group plc issues statement regarding NINGI Research report
Marex Group (NASDAQ: MRX), a diversified global financial services platform, has issued a strong rebuttal to a report published by NINGI Research, a short selling fund. The company categorically rejected the report as a malicious attempt to manipulate its share price for NINGI's profit from their short position.
Marex emphasized its commitment to regulatory compliance and high standards of integrity across all jurisdictions. The company affirmed that it reports financials in accordance with IFRS standards and maintains strong corporate governance. Marex will address the market and respond to analyst questions during its Q2 results announcement on August 13.
Marex Group (NASDAQ: MRX), una piattaforma globale di servizi finanziari diversificata, ha respinto con forza un rapporto pubblicato da NINGI Research, un fondo di vendita allo scoperto. L'azienda ha categoricamente rigettato il rapporto definendolo un tentativo malevolo di manipolare il prezzo delle sue azioni per il profitto di NINGI derivante dalla loro posizione corta.
Marex ha sottolineato il suo impegno per la conformit脿 normativa e per elevati standard di integrit脿 in tutte le giurisdizioni. La societ脿 ha confermato che i suoi bilanci sono redatti in conformit脿 con gli standard IFRS e mantiene una solida governance aziendale. Marex risponder脿 al mercato e alle domande degli analisti durante la presentazione dei risultati del secondo trimestre il 13 agosto.
Marex Group (NASDAQ: MRX), una plataforma global diversificada de servicios financieros, ha emitido una en茅rgica refutaci贸n a un informe publicado por NINGI Research, un fondo de venta en corto. La compa帽铆a rechaz贸 categ贸ricamente el informe como un intento malicioso de manipular el precio de sus acciones para beneficio de NINGI debido a su posici贸n corta.
Marex enfatiz贸 su compromiso con el cumplimiento normativo y altos est谩ndares de integridad en todas las jurisdicciones. La empresa afirm贸 que reporta sus estados financieros conforme a las normas IFRS y mantiene un s贸lido gobierno corporativo. Marex responder谩 al mercado y a las preguntas de los analistas durante el anuncio de resultados del segundo trimestre el 13 de agosto.
Marex Group (NASDAQ: MRX)電� 雼れ枒頃� 旮�搿滊矊 旮堨湹 靹滊箘鞀� 頂岆灚韽检溂搿滌劀, 瓿惦Г霃� 韼�霌滌澑 NINGI Research臧� 氚滍憸頃� 氤搓碃靹滌棎 雽�頃� 臧曤牓頌� 氚橂皶頄堨姷雼堧嫟. 須岇偓電� 頃措嫻 氤搓碃靹滊ゼ NINGI臧� 瓿惦Г霃� 韽靺橃棎靹� 鞚挫澋鞚� 鞏魂赴 鞙勴暅 鞎呾潣鞝侅澑 欤缄皜 臁办瀾 鞁滊弰搿� 雼樃頌� 瓯半秬頄堨姷雼堧嫟.
Marex電� 氇摖 甏�頃� 甑棴鞐愳劀 攴滌牅 欷�靾�鞕� 雴掛潃 靾橃鞚� 歆勳嫟靹� 鞙犾鞐� 雽�頃� 鞚橃毳� 臧曥“頄堨姷雼堧嫟. 須岇偓電� IFRS 旮办鞐� 霐半澕 鞛氤搓碃毳� 頃橁碃 鞛堨溂氅� 臧曤牓頃� 旮办梾 瓯半矂雱岇姢毳� 鞙犾頃橁碃 鞛堨潓鞚� 頇曥澑頄堨姷雼堧嫟. Marex電� 8鞗� 13鞚� 2攵勱赴 鞁れ爜 氚滍憸鞐愳劀 鞁滌灔鞐� 雽�鞚戫晿瓿� 鞎犽剱毽姢韸� 歆堧鞐� 雼惦硛頃� 鞓堨爼鞛呺媹雼�.
Marex Group (NASDAQ: MRX), une plateforme mondiale diversifi茅e de services financiers, a fermement r茅fut茅 un rapport publi茅 par NINGI Research, un fonds de vente 脿 d茅couvert. L'entreprise a cat茅goriquement rejet茅 ce rapport, le qualifiant de tentative malveillante de manipuler le cours de son action pour le profit de NINGI issu de leur position courte.
Marex a soulign茅 son engagement envers la conformit茅 r茅glementaire et des normes 茅lev茅es d'int茅grit茅 dans toutes les juridictions. La soci茅t茅 a affirm茅 qu'elle publie ses 茅tats financiers conform茅ment aux normes IFRS et maintient une gouvernance d'entreprise solide. Marex r茅pondra au march茅 et aux questions des analystes lors de la publication des r茅sultats du deuxi猫me trimestre le 13 ao没t.
Marex Group (NASDAQ: MRX), eine diversifizierte globale Finanzdienstleistungsplattform, hat eine scharfe Gegenreaktion auf einen von NINGI Research, einem Short-Selling-Fonds, ver枚ffentlichten Bericht herausgegeben. Das Unternehmen wies den Bericht kategorisch als b枚swilligen Versuch zur眉ck, den Aktienkurs zu manipulieren, um NINGIs Gewinn aus deren Short-Position zu sichern.
Marex betonte sein Engagement f眉r 搁别驳别濒办辞苍蹿辞谤尘颈迟盲迟 und hohe Integrit盲tsstandards in allen Rechtsgebieten. Das Unternehmen best盲tigte, dass es seine Finanzberichte gem盲脽 den IFRS-Standards erstellt und eine starke Unternehmensf眉hrung aufrechterh盲lt. Marex wird den Markt ansprechen und w盲hrend der Bekanntgabe der Quartalsergebnisse am 13. August Analystenfragen beantworten.
- Company maintains strong regulatory compliance and IFRS reporting standards
- Scheduled Q2 earnings release demonstrates transparency
- Short seller attack could impact stock price and investor confidence
- Presence of allegations requiring company response
LONDON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (鈥楳arex鈥� or the 鈥楪roup鈥�; NASDAQ: MRX),聽the diversified global financial services platform, provided the following response to the report that was published earlier today by NINGI Research, a short selling fund.
Marex rejects this malicious report as a transparent effort to manipulate the share price to enable NINGI to profit from the short position it previously built. The report was published without any involvement by Marex. The report contains factual inaccuracies, misstatements, and misleading allegations.
Marex is committed to the highest standards of integrity, managing its business in accordance with regulatory requirements in every jurisdiction where it operates. Marex reports its financial figures in accordance with international reporting standards (IFRS) and adheres to the highest standards of corporate governance.
Marex will report its second quarter results on Wednesday August 13, where we look forward to the opportunity to update the market on our recent performance and respond to analyst questions.
About Marex:
Marex Group plc (NASDAQ: MRX) is a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. The Group provides comprehensive breadth and depth of coverage across four services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to 60 exchanges. The Group provides access to the world鈥檚 major commodity markets, covering a broad range of clients that include some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 40 offices worldwide, the Group has over 2,400 employees across Europe, Asia and the Americas. For more information visit www.marex.com.
Enquiries please contact:
Marex:
Nicola Ratchford / Adam Strachan
+44 778 654 8889 / +1 914 200 2508
[email protected]/ [email protected]
FTI Consulting US / UK
+1 919 609 9423 / +44 777 611 1222
[email protected]
FAQ
What allegations did NINGI Research make against Marex Group (NASDAQ: MRX)?
How did Marex Group (NASDAQ: MRX) respond to the NINGI Research short seller report?
When will Marex Group (NASDAQ: MRX) address the NINGI Research allegations?
What financial reporting standards does Marex Group (NASDAQ: MRX) follow?
Is NINGI Research short selling Marex Group (NASDAQ: MRX) stock?
